Dyne Therapeutics CEO John Cox Sells $49,179 in Stock
John Cox, the CEO and President of Dyne Therapeutics, Inc. (NASDAQ:DYN), recently sold 2,683 shares of the company's common stock on June 16, 2026, for a total value of $49,179. The sale was executed to satisfy tax withholding obligations related to the vesting of restricted stock units granted to Mr. Cox on December 4, 2024. This transaction was a…